In conclusion, we show here that DPP-4 inhibition accelerates breast cancer cell survival by inducing autophagy through CXCL12/CXCR4-mediated mTOR/HIF-1α activation; metformin abrogates such alterations induced by DPP-4 suppression. Here, HIF1A is linked to breast cancer.